GrayMatters Health

𝐈𝐧 𝐑𝐞𝐦𝐞𝐦𝐛𝐫𝐚𝐧𝐜𝐞: The trauma of 9/11 left deep emotional and psychological scars, not only for those directly affected but for an entire nation. Studies found that PTSD was the most common health effect of 9/11. Up to 20% of adults directly exposed to the disaster or injured in the attack had PTSD symptoms 5-6 years after the attack - four times the rate in the general population. Those who repeatedly witnessed the events on television and in newspapers were at greater risk of developing long-term psychological challenges. On this day, we honor the lives lost and the resilience of a nation.

Meet Yaki Stern, Algorithm Engineer at GrayMatters Health! With 20+ years in neuroscience and a PhD in computational methods, Yaki develops algorithms and analyzes brain data to advance mental healthcare. His highlights include discovering ways to enhance fMRI scan quality and developing other digital-based biomarkers. Outside work, he unwinds with reading, running, and weekly volunteering.

Curious about how FDA-cleared Prism for PTSD works? Take a look at our non-trauma-based PTSD treatment.

According to GrayMatters Health’s CMO Dr. @AronTendler, while the debate around MDMA-AT for PTSD primarily focused on concerns of safety and efficacy, accessibility – its widespread use and access to patients - was largely overlooked.“ While rejection of MDMA-AT was a disappointment for many, its limited accessibility made the setback less significant than it was portrayed to be.” Read his latest commentary via @medcitynews and learn more about why accessibility is one of the three core pillars of all successful and viable medical treatments: medcitynews.com/2024/09/breaki…

Link to full data here: frontiersin.org/journals/psych…

In the expanding field of interventional psychiatry, the recent @FrontiersIn meta-analysis highlights neurofeedback as a promising PTSD treatment. The evidence is growing that Prism's fMRI-informed neurofeedback using the amygdala-based biomarker stands out as a highly effective treatment option. Link to the full data in the comments ⬇️

Read more: pharmaceutical-technology.com/features/after…

A recent Pharmaceutical-Technology article included commentary from Dr. @AronTendler, Chief Medical Officer of GMH, on the future of psychedelics for PTSD treatment. According to Dr. Tendler, psychedelics can be used with existing FDA-cleared treatments, like Prism for PTSD, to meet the needs of each individual patient.

Sharing a meal with the team from @GraymattersH

What an experience for GMH - being part of the first Home Base Brain Health Summit. At this summit, there was an exchange of ideas focused on interventions for the healthy minds and bodies of veterans and their families. The sessions were engaging, and as the speakers shared their insights, a talented illustrator captured it all in real-time, turning the discussions into creative visuals. Thank you @homebaseprogram, the @PsychFoundation and the @wwp. We are better, together.

At GMH we believe that mental health is as vital as physical health. Despite advancements, barriers to accessing mental health care persist – even for insured Americans. We applaud efforts aimed at making mental health care as accessible as physical health care. Check out Lev Facher’s latest piece via @statnews: statnews.com/2024/09/09/ins…

Dr. @AronTendler will be presenting a poster, Amygdala-EFP Neurofeedback: Effect on PTSD Symptom Clusters on Saturday, September 28, 2024, at @ISTSSnews in Boston. This research presents the findings of additional analysis performed on individual CAPS-5 symptom clusters from the Prism for PTSD clinical study. Results highlight Prism’s potential as a comprehensive adjunctive treatment in the management of PTSD.

@dustinrhodes Thank you for using your platform and voice to spread awareness about mental health challenges.

How is your mental health today? Do you have a support group? If you do, use them. Talk with them. Ask for help. It is out there but they don't know you have mental health issues until you ask them for help. Be proactive about your well being and know that there are millions of us just like you. Just breathe babe!!! ❤️ #KeepSteppin

"Even if you've accumulated a house full of nice things, and the picture of your life fits inside a beautiful frame, if you have experienced trauma but haven't excavated it, the wounded parts of you will affect everything you've managed to build." ~ @Oprah If this quote speaks to you, you are not alone. The first step towards recovery is always the hardest. Start here: Check out the @APApsychiatric's database of mental healthcare providers to find resources near you. finder.psychiatry.org/s/

GrayMatters Health is proud to be a part of the @homebaseprogram Brain Health Summit, “Promoting HealthSpan Through Collaboration and Innovation”, to be held on September 11-12, 2024 at The MGH Institute of Health Professions in Boston, MA. The date of the inaugural Brain Health Summit is significant - to reflect on the progress made since the September 11th attacks. The Brain Health Summit will examine the latest research and treatment innovations in military Special Operations Forces, veterans, and families suffering from the invisible wounds of war.  Home Base, a @RedSoxFund and Massachusetts General Hospital Program, will provide comprehensive insights and in-depth information on brain health, resiliency, PTSD and TBI with interactive demos highlighting emerging innovative treatments such as Virtual Reality, Vestibular Rehabilitation, Performance, and amygdala-based neurofeedback. GMH's CEO and Co-Founder, Oded Kraft, CCO, Kirk Thelander and Clinical Applications Specialist, Rebecca Manda will be there! Learn more: #group-tabs-node-course-default1" target="_blank" rel="nofollow noopener">lms.mghcme.org/lms.homebase.o…   @PsychFoundation @wwp

Accessibility in mental healthcare is crucial for everyone to get the support they need. This means tackling barriers like: 🌍 Geographical limitations 💸 Financial constraints 🌐 Operational constraints 📈 Scalability Everyone deserves the chance to thrive! 💙

Dr. @AronTendler, CMO of GMH, explores how Prism uses a proprietary brain biomarker to help patients learn to regulate brain activity associated with PTSD.

According to @Forbes, a cumulative 12B workdays are lost annually to anxiety & depression, costing $1T. In the U.S., 20% of workers consider quitting daily, and 88% feel burned out. Employee burnout highlights the urgent need for mental health support. Prioritizing mental health is essential for a resilient and productive workforce.